Savant Capital, LLC Terns Pharmaceuticals, Inc. Transaction History
Savant Capital, LLC
- $12.3 Billion
- Q4 2024
A detailed history of Savant Capital, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 16,083 shares of TERN stock, worth $75,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,083Holding current value
$75,590% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TERN
# of Institutions
170Shares Held
78.4MCall Options Held
580KPut Options Held
454K-
Orbimed Advisors LLC San Diego, CA7.56MShares$35.5 Million1.49% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$32.4 Million8.42% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.22MShares$29.3 Million4.41% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$26.2 Million1.71% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$19.4 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $177M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...